Severe Hypoglycemia from Helicobacter Pylori Triple-Drug Therapy and Insulin Detemir Drug Interaction

2013 ◽  
Vol 33 (4) ◽  
pp. e45-e49 ◽  
Author(s):  
Shelley H. Otsuka
Keyword(s):  
Helicobacter Pylori ◽  
Drug Interaction ◽  
Drug Therapy ◽  
Insulin Detemir ◽  
Severe Hypoglycemia

scholarly journals Factors affecting general practitioners’ choice of drug therapy: A study in primary healthcare in Iceland

2021 ◽  
Vol 107 (11) ◽  
pp. 522-527
Author(s):  
Yrsa Ívarsdóttir ◽  
◽  
Jón Steinar Jónsson ◽  
Kristján Linnet ◽  
Anna Bryndís Blöndal ◽  
...  
Keyword(s):  
Primary Care ◽  
Decision Making ◽  
Drug Interaction ◽  
Drug Therapy ◽  
Primary Care Physicians ◽  
New Drugs ◽  
Factors Affecting ◽  
Face To Face ◽  
Software Information ◽  
Strongly Agree

Introduction: This study aimed to analyse several factors that influence the decision-making of primary care physicians in Iceland in their choice of drug therapy for their patients. Also, to find which factors can act as a hindrance in making the best choices. Finally, to analyse which elements could be most important in facilitating decisions. Material and methods: A questionnaire was sent by e-mail to physicians working in primary care in Iceland. The questionnaire comprised closed questions, open text boxes, and ranking questions. The data was processed and analysed using Microsoft Excel. Results: The total number of primary care physicians who responded to the questionnaire was 93, a response rate of 40.7% of all the primary care physicians. The results reveal that physicians working in primary care consider clinical guidelines, the Icelandic National Formulary, and personal experience to be the most important factors when choosing a medication. Primary care physicians strongly agree that the lack of drug interaction software connected to medical records is a shortcoming. The most important factors that need improvement to facilitate primary care physicians' decision-making are drug formularies and interaction software. Conclusion: The results suggest some factors that support physicians in primary care in making decisions when choosing drug therapy, such as a drug formulary, drug interaction software, information about patients’ drug therapy, variable length in face-to-face consultations, evidence based information on new drugs, and counselling provided by clinical pharmacists.

scholarly journals Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia

2016 ◽  
Vol 32 (10) ◽  
pp. 1719-1725 ◽  
Author(s):  
Ulrik Pedersen-Bjergaard ◽  
Peter Lommer Kristensen ◽  
Kirsten Nørgaard ◽  
Hans Perrild ◽  
Tonny Jensen ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Cost Effectiveness ◽  
Insulin Aspart ◽  
Insulin Detemir ◽  
Severe Hypoglycemia ◽  
Short Term

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

2007 ◽  
Vol 146 (8) ◽  
pp. 556 ◽  
Author(s):  
Dino Vaira ◽  
Angelo Zullo ◽  
Nimish Vakil ◽  
Luigi Gatta ◽  
Chiara Ricci ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Drug Therapy ◽  
Sequential Therapy ◽  
Helicobacter Pylori Eradication

Severe Hypoglycemia From Clarithromycin-Sulfonylurea Drug Interaction

Diabetes Care ◽  
2002 ◽  
Vol 25 (9) ◽  
pp. 1659-1661 ◽  
Author(s):  
R. Bussing ◽  
A. Gende
Keyword(s):  
Drug Interaction ◽  
Severe Hypoglycemia

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study

2013 ◽  
Vol 69 (9) ◽  
pp. 1709-1715 ◽  
Author(s):  
Hassan Seddik ◽  
Samir Ahid ◽  
Tarek El Adioui ◽  
Fatim-Zohra El Hamdi ◽  
Mohammed Hassar ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Drug Therapy ◽  
Randomized Study ◽  
Sequential Therapy ◽  
Prospective Randomized Study ◽  
Helicobacter Pylori Eradication

Impact of Patient-Specific Drug Interaction Information on Physician Prescribing Patterns

1980 ◽  
Vol 14 (4) ◽  
pp. 280-283
Author(s):  
Thomas R. Adams ◽  
William J. Murray ◽  
J. Heyward Hull
Keyword(s):  
Drug Interaction ◽  
Drug Therapy ◽  
Drug Interactions ◽  
Prescribing Patterns ◽  
Study Patient ◽  
Patient Specific ◽  
Utilization Review ◽  
Control Groups ◽  
Anticoagulant Drug ◽  
Physician Prescribing

Patient exposure to potential anticoagulant drug interactions was identified by computerized drug-therapy surveillance, as part of a peer-review program. To evaluate the response of clinicians provided with data on the potential drug interactions, 119 “exposed” patients were randomly divided and assigned to study or control groups. Physicians prescribing for the 60 study patients were informed of the potential problem by letter and were furnished with information on the drug interaction, while the 59 control patients were only monitored. Physicians provided with the information made statistically more changes in drug therapy than those not informed ( p < 0.05). Over 75 percent of study-patient physicians responding to a questionnaire accompanying the drug interaction data indicated that the service was useful and should be expanded to other drugs. Application of methods similar to that used in this study should offer drug utilization review committees an effective approach to improving drug therapy.

Sign in / Sign up

Export Citation Format

Share Document